News

Sun Pharma to ramp up specialty products portfolio in FY26 to drive growth
The company projects revenue growth of mid- to high single digits in FY26 compared with an 8.5% increase in FY25 ...
Checkpoint Therapeutics Beats Investor Suit Over FDA Approval
Checkpoint Therapeutics Inc. defeated investor claims it concealed the likelihood US regulators would deny its skin cancer ...
NDTV Profit on MSN3d
Sun Pharma's Checkpoint Bid Seen As A Strategic Win By Macquarie
Macquarie has reaffirmed its ‘outperform’ rating on Sun Pharmaceutical Industries Ltd. and raised its target price to Rs ...
Nasdaq8d
Fortress Biotech Launches Emrosi™ for Rosacea Treatment and Announces Checkpoint Therapeutics Acquisition by Sun Pharma
The company also reported a planned acquisition of its subsidiary Checkpoint Therapeutics by Sun Pharmaceutical ... Fortress’ robust pipeline — including multiple late-stage programs and ...
Morningstar10d
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
Please see full Prescribing Information. About Checkpoint Therapeutics Checkpoint Therapeutics, Inc. is a commercial-stage immunotherapy and targeted oncology company focused on the acquisition ...
Finanznachrichten9d
Checkpoint Therapeutics, Inc: Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
May 13, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial results for ...